NDM-1 inhibitors (Priaxon)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameNDM-1 inhibitors (Priaxon)
Drug Alias NameNew Delhi metallo-beta-lactamase-1 inhibitors (Priaxon)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBeta Lactamase inhibitors
TargetsBeta Lactamase
Therapy Area/IndicationsBacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPriaxon Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPriaxon Inc
Active IndicationsN/A
Inactive IndicationsBacterial Infections

Other Information

ATC CodeN/A
Related LinksN/A